Biological Products, (No Diagnostic Substances)·PHILADELPHIA, PA
Financials
20 shown
Type
Period
Ended
Filed
10-Q
Q3 2025
9/30/25
11/10/25
→
10-Q
Q2 2025
6/30/25
8/7/25
→
10-Q
Q1 2025
3/31/25
5/15/25
→
10-K
FY 2024
12/31/24
3/31/25
→
10-Q
Q3 2024
9/30/24
11/14/24
→
10-Q
Q2 2024
6/30/24
8/8/24
→
↓
Earnings Releases (8-K)
26 shown
Filed
Period
11/10/25
Q4 FY2025
→
8/7/25
Q3 FY2025
→
5/15/25
Q2 FY2025
→
3/31/25
Q1 FY2025
→
1/13/25
Q4 FY2025
→
11/14/24
Q4 FY2024
→
↓
News (8-K)
54 shown
Filed
Type
Description
1/12/26
Reg FD
Regulation FD Disclosure
→
10/29/25
Other
Other Events
→
10/27/25
Reg FD
Regulation FD Disclosure
→
10/9/25
Reg FD
Regulation FD Disclosure
→
9/3/25
Reg FD
Regulation FD Disclosure
→
6/12/25
Agreement
Entry into a Material Definitive Agreement
→
↓
Prospectuses & Registrations
27 shown
Filed
Form
Description
8/7/25
S-3
S-3
→
6/12/25
424B5
424B5
→
6/11/25
424B5
424B5
→
5/13/25
ARS
ARS
→
3/31/25
S-8
S-8
→
3/31/25
POSASR
POSASR
→
↓
Filing History(408 filings)
TypeDateAccessionPeriodSize
4
Mar 2, 2026
0001193125-26-0861454
Mar 2, 2026
5.3 KB
4
Mar 2, 2026
0001193125-26-0861434
Mar 2, 2026
5.3 KB
4
Mar 2, 2026
0001193125-26-0861354
Mar 2, 2026
5.3 KB
4
Mar 2, 2026
0001193125-26-0861294
Mar 2, 2026
5.3 KB
4
Mar 2, 2026
0001193125-26-0861234
Mar 2, 2026
5.3 KB
4
Mar 2, 2026
0001193125-26-0861184
Mar 2, 2026
5.3 KB
SCHEDULE 13G
Feb 18, 2026
0001104659-26-017121
—
14.8 KB
SCHEDULE 13G/A
Feb 17, 2026
0001172661-26-001156
—
10.5 KB
SCHEDULE 13G/A
Feb 17, 2026
0001172661-26-001031
—
10.1 KB
SCHEDULE 13G/A
Feb 17, 2026
0001897612-26-000278
—
9.1 KB
4
Jan 21, 2026
0001193125-26-0183274
Jan 21, 2026
4.3 KB
4
Jan 21, 2026
0001193125-26-0183254
Jan 21, 2026
4.3 KB
4
Jan 21, 2026
0001193125-26-0183244
Jan 21, 2026
4.5 KB
4
Jan 21, 2026
0001193125-26-0183234
Jan 21, 2026
4.9 KB
4
Jan 21, 2026
0001193125-26-0183194
Jan 21, 2026
4.3 KB
4
Jan 21, 2026
0001193125-26-0183184
Jan 21, 2026
5.9 KB
4
Jan 21, 2026
0001193125-26-0183174
Jan 21, 2026
5.5 KB
4
Jan 21, 2026
0001193125-26-0183164
Jan 21, 2026
4.8 KB
8-K
Jan 12, 2026
0001193125-26-0098198-K
Jan 12, 2026
24.7 MB
SCHEDULE 13G/A
Nov 14, 2025
0001172661-25-005189
—
10.5 KB
SCHEDULE 13G/A
Nov 14, 2025
0001104659-25-112515
—
18.1 KB
SCHEDULE 13G/A
Nov 14, 2025
0001172661-25-004955
—
11.3 KB
10-Q
Nov 10, 2025
0001193125-25-27328010-Q
Sep 30, 2025
8.8 MB
8-K
Nov 10, 2025
0001193125-25-2732728-K
Nov 10, 2025
317.2 KB
SCHEDULE 13G/A
Nov 7, 2025
0001137774-25-000181
—
7.1 KB
25 filings shown
Cabaletta Bio, Inc. — SlamSEC
Proxies
11 shown
Filed
Form
Description
5/13/25
DEF 14A
DEF 14A
→
4/30/25
PRE 14A
PRE 14A
→
4/23/24
DEFA14A
DEFA14A
→
4/23/24
DEF 14A
DEF 14A
→
4/21/23
DEFA14A
DEFA14A
→
4/21/23
DEF 14A
DEF 14A
→
↓
Ownership
40 shown
Filed
Form
Description
3/2/26
4
4
→
3/2/26
4
4
→
3/2/26
4
4
→
3/2/26
4
4
→
3/2/26
4
4
→
3/2/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/18/26
SCHEDULE 13G
SCHEDULE 13G
→
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/17/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
11/14/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
11/14/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
↓
Cabaletta is a two-part musical form particularly favored for arias in 19th century Italian opera in the bel canto era until about the 1860s during which it was one of the era's most important elements. More properly, a cabaletta is a more animated section following the songlike cantabile.